Search or choose
Find the right test or package.
JMML Risk Stratification Gene Panel
Juvenile Myelomonocytic Leukemia (JMML) risk stratification via Next-Generation Sequencing (NGS) involves analyzing a panel of genes associated with the disease. This panel typically includes genes like PTPN11, NRAS, KRAS, CBL, and others. By identifying mutat...
DiagnosticsLab test
Know more about this test
Juvenile Myelomonocytic Leukemia (JMML) risk stratification via Next-Generation Sequencing (NGS) involves analyzing a panel of genes associated with the disease. This panel typically includes genes like PTPN11, NRAS, KRAS, CBL, and others. By identif...
Understanding JMML Risk Stratification Gene Panel
Juvenile Myelomonocytic Leukemia (JMML) risk stratification via Next-Generation Sequencing (NGS) involves analyzing a panel of genes associated with the disease. This panel typically includes genes like PTPN11, NRAS, KRAS, CBL, and others. By identifying mutations in these genes, NGS assists in categorizing JMML patients into low, intermediate, or high-risk groups, which helps guide treatment decisions and predict disease progression. The specific genetic profile revealed by NGS informs personalized care strategies...
What does JMML Risk Stratification Gene Panel measure?
Juvenile Myelomonocytic Leukemia (JMML) risk stratification via Next-Generation Sequencing (NGS) involves analyzing a panel of genes associated with the disease. This panel typically includes genes like PTPN11, NRAS, KRAS, CBL, and others. By identifying mutations in these genes, NGS assists in categorizing JMML patients into low, intermediate, or high-risk groups, which helps guide treatment decisions and predict disease progression. The specific genetic profile revealed by NGS informs personalized care strategies...
Related parameters
How does home sample collection work?
Select slot
Pick a convenient time.
Phlebotomist visit
A trained expert arrives home.
Safe testing
Samples move through the lab process.
Digital reports
Reports are delivered online.